Published in Am J Cardiol on July 01, 1991
Angiotensin converting enzyme inhibitors for hypertension and heart failure? Postgrad Med J (1992) 1.52
Angiotensin-converting inhibitors in patients with congestive heart failure: a class effect? Am J Cardiol (1991) 0.84
Optimising heart failure pharmacotherapy: the ideal combination. Br Heart J (1994) 0.75
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med (1996) 11.76
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol (1995) 4.50
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
[Acute coronary syndromes. Simplified routines with early exercise test performed at the intensive coronary care units]. Lakartidningen (1993) 3.19
Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol (1981) 3.12
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet (1998) 3.03
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J (2004) 2.80
The teeth and infective endocarditis. Br Heart J (1983) 2.53
A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation (1982) 2.22
Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation (1997) 2.13
Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol (1983) 2.10
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor. Ann Oncol (2012) 2.02
Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Eur J Surg Oncol (2013) 1.99
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J (1981) 1.91
Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine (1973) 1.90
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J (1996) 1.83
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J (1997) 1.76
Prevention of infective endocarditis. Br Heart J (1981) 1.74
Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care (1999) 1.72
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation (1992) 1.65
Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. Eur Heart J (2000) 1.60
Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest (1998) 1.60
Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol (1994) 1.46
Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ (1994) 1.46
Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease. Circulation (1977) 1.46
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J (1981) 1.46
Social relations and extent and severity of coronary artery disease. The Stockholm Female Coronary Risk Study. Eur Heart J (1998) 1.45
Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J (1998) 1.44
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia (2005) 1.44
Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J (2002) 1.42
Diastolic function of the nonfilling human left ventricle. J Am Coll Cardiol (1992) 1.41
Phenformin and pulmonary hypertension. Br Heart J (1973) 1.40
A new apparatus for detection of impending pacemaker failure in patients treated with implanted pacemakers. Cardiovasc Res (1970) 1.39
Angiographic evaluation of vasomotor properties of internal mammary arteries before and after coronary artery bypass grafting in men. Am J Cardiol (1990) 1.39
Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein. J Biol Chem (1978) 1.37
Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J (1995) 1.37
Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry (1976) 1.36
Pressures of work on doctors and family. Br Med J (1976) 1.36
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer (2004) 1.36
A rapid and specific method for isolation of thiol-containing peptides from large proteins by thiol-disulfide exchange on a solid support. Proc Natl Acad Sci U S A (1975) 1.33
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. Eur Heart J (2000) 1.31
Re-used pacemakers--as safe as new? A retrospective case-control study. Eur Heart J (1998) 1.31
Myocardial infarction in patients with diabetes mellitus. Eur Heart J (1988) 1.30
Use of antibiotics. Endocarditis. Br Med J (1978) 1.29
Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology. J Heart Valve Dis (1993) 1.29
Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. Eur Heart J (1999) 1.28
Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis. J Intern Med (1989) 1.26
The mechanism of injury in blunt traumatic rupture of the aorta. Eur J Cardiothorac Surg (2002) 1.26
Mode of death in heart failure: findings from the ATLAS trial. Heart (2003) 1.24
Improved physical fitness and quality of life following training of elderly patients after acute coronary events. A 1 year follow-up randomized controlled study. Eur Heart J (1999) 1.23
Pregnancy in patients after valve replacement. Br Heart J (1976) 1.22
Antianginal effects of corwin, a new beta-adrenoceptor partial agonist. Am J Cardiol (1984) 1.22
Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (1995) 1.21
Quality-of-life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: a long-term, double-blind, crossover study. Pacing Clin Electrophysiol (1992) 1.21
Oral contraceptives and progressive pulmonary vascular disease. Lancet (1968) 1.20
Aortic valve replacement in octogenarians with aortic stenosis: a case-control study. J Am Coll Cardiol (1992) 1.18
Ventricular hypertrophy in cardiomyopathy. Br Heart J (1971) 1.16
Physiological versus single-rate ventricular pacing: a double-blind cross-over study. Pacing Clin Electrophysiol (1985) 1.16
Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Eur Heart J (1982) 1.16
Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. Br Heart J (1993) 1.15
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. J Am Coll Cardiol (2000) 1.15
Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand (1988) 1.15
Single-chain structure of human ceruloplasmin. Eur J Biochem (1972) 1.14
The effect of ventricular activation sequence on cardiac performance during pacing. Pacing Clin Electrophysiol (1996) 1.14
Comparison of physical work capacity and systolic time intervals with ventricular inhibited and atrial synchronous ventricular inhibited pacing. Br Heart J (1981) 1.14
Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Ther (1994) 1.13
The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.13
Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart (2004) 1.12
Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine. Circulation (1980) 1.12
Molecular weight of beef heart aconitase and stoichiometry of the components of its iron-sulfur cluster. J Biol Chem (1984) 1.12
Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J (2001) 1.12
Isolation and properties of a staphylococcal protease, preferentially cleaving glutamoyl-peptide bonds. Eur J Biochem (1974) 1.12
Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction. Clin Pharmacol Ther (1980) 1.10
Causes of more frequent deletions than insertions in mutations and protein evolution. Nature (1981) 1.10
Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J (1999) 1.09
Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08
Q waves and coronary angiography in cardiomyopathy. Br Heart J (1970) 1.08
Wolff-Parkinson-White syndrome type A obscured by left bundle branch block. Eur J Cardiol (1977) 1.07
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial. J Clin Pathol (2005) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol (1999) 1.06
Coronary arteriography in acute transmural myocardial infarction. Am Heart J (1979) 1.05
Sustained effect of hydralazine in long term treatment of CHF. Acta Med Scand Suppl (1981) 1.05
Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail (2000) 1.04
Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res (1993) 1.04
Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol (1995) 1.04
Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease. Cardiovasc Res (1973) 1.03
Hypertrophy and obstruction of outflow tract of left ventricle. Br Heart J (1970) 1.01
The amino-acid sequences of three tryptic glycopeptides from human ceruloplasmin. Eur J Biochem (1974) 1.01
Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents. Acta Med Scand (1981) 1.01
Effect of lignocaine on heart rate in patients with sinus bradycardia associated with proven or suspected acute myocardial infarction. Cardiovasc Res (1972) 1.01
Clinical and electrophysiological characteristics of a transvenous atrial lead. Br Heart J (1979) 1.00